Advanced search
Publication Cover
Bioengineered Volume 13, 2022 - Issue 3
Submit an article Journal homepage
744
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA breast cancer-associated transcript 54 sponges microRNA-1269b to suppress the proliferation of hemangioma-derived endothelial cells

Zhonjun LvDepartment of Vascular Surgery, Nanyang Central Hospital, Nanyang, Henan Province, ChinaView further author information
,
Ke YangDepartment of Vascular Surgery, Nanyang Central Hospital, Nanyang, Henan Province, ChinaView further author information
&
Ya WangDepartment of Vascular Surgery, Nanyang Central Hospital, Nanyang, Henan Province, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1207-2453View further author information
ORCID Icon
Pages 6188-6195 | Received 19 Nov 2021, Accepted 04 Jan 2022, Published online: 24 Feb 2022

References

  • Holland KE, Drolet BA. Infantile hemangioma. Pediatr Clin North Am. 2010 Oct;57(5):1069–1083.
  • Seiffert A, Schneider M, Roessler J, et al. Incidence, treatment patterns, and health care costs of infantile hemangioma: results of a retrospective German database analysis. Pediatr Dermatol. 2017 Jul;34(4):450–457.
  • Chen ZY, Wang QN, Zhu YH, et al. Progress in the treatment of infantile hemangioma. Ann Transl Med. 2019 Nov;7(22):692.
  • Chang L, Lv D, Yu Z, et al. Infantile hemangioma: factors causing recurrence after propranolol treatment. Pediatr Res. 2018 Jan;83(1–1):175–182.
  • Darrow DH, Greene AK, Mancini AJ, et al. Diagnosis and management of infantile hemangioma. Pediatrics. 2015 Oct;136(4):e1060–104.
  • Tiemann L, Hein S. Infantile hemangioma: a review of current pharmacotherapy treatment and practice pearls. J Pediatr Pharmacol Ther. 2020;25(7):586–599.
  • Koh SP, Leadbitter P, Smithers F, et al. β-blocker therapy for infantile hemangioma. Expert Rev Clin Pharmacol. 2020 Aug;13(8):899–915.
  • Thai T, Wang CY, Chang CY, et al. Central nervous system effects of oral propranolol for infantile hemangioma: a systematic review and meta-analysis. J Clin Med. 2019 Feb 22;8(2):268.
  • Boye E, Olsen BR. Signaling mechanisms in infantile hemangioma. Curr Opin Hematol. 2009 May;16(3):202–208.
  • Ji Y, Chen S, Li K, et al. Signaling pathways in the development of infantile hemangioma. J Hematol Oncol. 2014 Jan 31;7:13.
  • Greenberger S, Adini I, Boscolo E, et al. Targeting NF-κB in infantile hemangioma-derived stem cells reduces VEGF-A expression. Angiogenesis. 2010 Dec;13(4):327–335.
  • Liu X, Lv R, Zhang L, et al. Long noncoding RNA expression profile of infantile hemangioma identified by microarray analysis. Tumour Bio. 2016 Oct 5;37(12):15977–15987.
  • Li J, Li Q, Chen L, et al. Competitive endogenous RNA networks: integrated analysis of non-coding RNA and mRNA expression profiles in infantile hemangioma. Oncotarget. 2018 Feb 23;9(15):11948–11963.
  • Dai Y, Qiu M, Wang S, et al. lncRNA CASC2 suppresses the growth of hemangioma cells by regulating miR-18a-5p/FBXL3 axis. J Biol Regul Homeost Agents. 2020;34(1):49–56.
  • Zhang J, Zhao T, Tian L, et al. LncRNA OIP5-AS1 promotes the proliferation of hemangioma vascular endothelial cells via regulating miR-195-5p/NOB1 axis. Front Pharmacol. 2019;10:449.
  • Yang W, Qian Y, Gao K, et al. LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes. Carcinogenesis. 2021 Feb 11;42(1):80–92.
  • Chen L, Liu D, Yi X, et al. The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway. Cell Death Dis. 2020 May 5;11(5):320.
  • Yang W, Xiao W, Cai Z, et al. miR-1269b drives cisplatin resistance of human non-small cell lung cancer via modulating the PTEN/PI3K/AKT signaling pathway. Onco Targets Ther. 2020;13:109–118.
  • Livak K, Schmittgen T. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
  • Smith CJF, Friedlander SF, Guma M, et al. Infantile hemangiomas: an updated review on risk factors, pathogenesis, and treatment. Birth Defects Res. 2017 Jul 3;109(11):809–815.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.